Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab

Basit Öğe Kaydı
dc.authoridYILMAZ, Hatice/0000-0001-5341-5646
dc.authoridKOBAK, SENOL/0000-0001-8270-640X
dc.contributor.authorKobak, Senol
dc.contributor.authorYilmaz, Hatice
dc.contributor.authorGuclu, Oguz
dc.contributor.authorOgretmen, Zerrin
dc.date.accessioned2025-01-27T21:21:15Z
dc.date.available2025-01-27T21:21:15Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractRheumatoid arthritis is a chronic erosive rheumatic disease that can present with polyarticular involvement. Anti-TNF-alpha drugs are used in cases that are resistant to traditional disease-modifying antirheumatic drugs (DMARDs). Anti-TNF-alpha drugs are groundbreaking drugs, the efficacy of which has been proven in the treatment of rheumatoid arthritis. However, the data concerning safety remain limited and contradictory. The risk of tuberculosis reactivation, various infections, as well as lymphoproliferative disease and/ or secondary malignancy is a matter of discussion. In this report, we report a 52-year-old male patient using adalimumab for active rheumatoid arthritis who presented to our polyclinic with generalized mouth and throat sores, hoarseness, and swallowing difficulty. Candida laryngitis was detected in the laryngoscopy and culture samples. Adalimumab was discontinued, and the infection was controlled with anti-fungal treatment.
dc.identifier.doi10.5152/eurjrheumatol.2014.140001
dc.identifier.endpage169
dc.identifier.issn2147-9720
dc.identifier.issn2148-4279
dc.identifier.issue4
dc.identifier.pmid27708907
dc.identifier.startpage167
dc.identifier.trdizinid223689
dc.identifier.urihttps://doi.org/10.5152/eurjrheumatol.2014.140001
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/223689
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28859
dc.identifier.volume1
dc.identifier.wosWOS:000218668500011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofEuropean Journal of Rheumatology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectRheumatoid arthritis
dc.subjectcandida laryngitis
dc.subjectadalimumab
dc.titleSevere candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu